Purpose The worldwide prevalence of human papillomavirus (HPV) infection is estimated at 9-13 %. Persistent infection can lead to the development of malignant and nonmalignant diseases. Low-risk HPV types are mostly associated with benign lesions such as anogenital warts. In the present systematic review, we examined the impact of smoking on HPV infection and the development of anogenital warts, respectively. Methods A systematic literature search was performed using MEDLINE database for peer-reviewed articles published from January 01, 1985 to November 30, 2013. Pooled rates of HPV prevalence were compared using the χ 2 test. Results In both genders, smoking is associated with higher incidence and prevalence rates for HPV infection, whereas the latter responds to a dose-effect relationship. The overall HPV prevalence for smoking patients was 48.2 versus 37. 5 % for nonsmoking patients (p<0.001) (odds ratio (OR)=1.5, 95 % confidence interval (CI) 1.4-1.7). Smoking does also increase persistence rates for high-risk HPV infection, while this correlation is debatable for low-risk HPV. The incidence and recurrence rates of anogenital warts are significantly increased in smokers.
Introduction
According to the World Health Organization (WHO), 630 million people are infected with genital human papillomavirus (HPV), resulting in an estimated worldwide prevalence of 9-13 % [1, 2] . HPV is transmitted via genital contact and is the most common sexually transmitted infection worldwide [3, 4] . There is no consensus on a gender-specific risk of acquiring HPV [5] . Whereas at least 40 % of HPVinfections are asymptomatic and transient, with subsequent clearance by the immune system, some infections persist [2, 5] . Persistent infection can lead to the development of malignant and premalignant or nonmalignant diseases, so-called "anal intraepithelial neoplasia" (AIN). Over 100 HPV types have been identified. Approximately 40 of these affect the anogenital region [2, 6] . HPV infections are detected by collecting material with brushes or swabs, followed by polymerase chain reaction analysis, genotyping, and HPV classification according to their risk of causing cervical cancer [2] : Low-risk HPV types are mostly associated with benign lesions such as anogenital warts (AIN grade I), and high-risk or oncogenic types are also associated with cancers and their precursors (AIN grade II/III) [6] . More than 90 % of anogenital warts are caused by low-risk HPV types 6 and 11 [7, 8] . Infected basal cells move toward the surface layer, where they ultimately develop to anogenital warts [2] . The worldwide prevalence of visible anogenital warts ranges from 0.13 to 5.1 % [9] . These may regress spontaneously, with reported clearance rates varying widely from 0 to 55 % [10] [11] [12] . However, even with therapy (topical, surgical, and/or destructive), the recurrence rate within 3 months is 25-67 % [10] .
Apart from genital contact, risk factors for HPVacquisition include younger age, early coitarche, number of lifetime sexual partners, failure to use condoms consistently, marital status, history of sexually transmitted infections, immunosuppression (including patients with human immunodeficiency virus), history of other HPV-mediated neoplasia, and low socioeconomic status [13, 4] . Furthermore, smoking is postulated to be an additional risk factor, due to increased susceptibility to the acquisition of HPV [14] .
In the present systematic review, we examined the impact of smoking on the incidence, persistence, and prevalence of HPVand of anogenital warts.
Methods
A systematic literature search was performed using MEDLINE database for peer-reviewed articles published in English. The search was carried out for articles published from January 01, 1985 to November 30, 2013, using the following keywords: smoking AND human papillomavirus AND/OR incidence AND/OR prevalence AND/OR persistence AND/OR condylomata acuminata AND/OR anogenital warts AND/OR genital warts. The references in the identified articles were also reviewed. Titles and abstracts, when available, were scrutinized to select relevant studies addressing the relation of smoking and HPV infection and/or the occurrence of anogenital warts. All studies addressing the relation in the abstract and/or the full text manuscript were subsequently included. Case reports, letters to editors, and review articles were excluded. In addition, studies restricted to patients with cervical or AIN and cervical or anal cancer were excluded. Furthermore, studies examining HPV infection or warts in other regions than the genital or anal were excluded.
Pooled rates of HPV prevalence were compared between smoking and nonsmoking patients, using the χ 2 test. For this analysis, only prospective studies were included. As time intervals for incidence and persistence were different between studies with an analysis of different HPV types, comparison of these pooled rates was not practicable. To assess the clinical significance of differences in prevalence rates between smoking and nonsmoking patients, the 95 % confidence interval (CI) for the difference was derived. Statistical Package for Social Sciences (SPSS Windows) version 21.0 (SPSS, Chicago, IL) was used for all analyses. There are ten studies comparing current with past smoking with regard to the prevalence of HPV [49, 51, 40, 61, 19, 14, 69, 72, 77, 90] . Except for one study, no impact of past smoking on the prevalence of HPV was shown [49, 51, 40, 61, 19, 14, 69, 72, 77] .
Results

Incidence of HPV
Four cross-sectional studies among current smokers showed increasing prevalence of HPV with the number of cigarettes smoked [49, 50, 14, 69] OR odds ratio, HR hazard ratio consistently found a significant association between smoking and high-risk HPV incidence. Regarding persistence of high-risk HPVinfection, three out of four prospective studies with a total of 827 patients revealed a significant association with smoking [32, 39, 38], whereas one study with 7,418 patients did not [37] .
An analysis of HPV types in female patients revealed no significant difference in prevalence of high-or low-risk HPV genotypes when comparing female smokers to nonsmokers [99] . In two prospective studies including a total of 13,234 patients, a significant impact of smoking on the prevalence of high-risk HPV was found [19, 41] .
Development of anogenital warts
Smoking has been shown to significantly increase the incidence of anogenital warts ( Table 3 ). The risk of developing anogenital warts increases with the number Anogenital Yes ---OR odds ratio, HR hazard ratio of cigarettes smoked per day and the number of packyears [13, [100] [101] [102] . However, this association only applies to current but not to past smoking [103, 104] . Luu et al. investigated the impact of current smoking on the size of anal warts but failed to find a relationship [105] . Smoking for 10 or more years has been found to increase the risk of recurrent genital warts (relative risk (RR)=4.5, 95 % CI 1.4-13.8) [106] .
Discussion
In both genders, smoking is associated with higher incidence and prevalence rates for HPV infection, whereas the latter responds to a dose-effect relationship.
Smoking does also increase persistence rates for highrisk HPV infection, while this correlation is debatable for low-risk HPV. The incidence and recurrence rates of anogenital warts are significantly increased in current smokers.
Smoking has deleterious effects on systemic and local immunity, as it suppresses both cell-mediated and humoral immune responses, which might lead to the present finding of increased susceptibility to HPV infection and development of anogenital warts [107] . Nicotine, the addictive substance in cigarette smoke, has been shown to be the main immunosuppressive constituent of cigarette smoke [107] . Moreover, smoking has been found to increase metaplasia and DNA damage in various tissues [108] [109] [110] [111] .
Although most studies adjusted for sexual behavior, unmeasured high-risk sexual behavior might be a potentially important confounder in the association between smoking and the incidence of HPV infection [16, 15, 26] . This is supported by Herrero et al., who found that sex with multiple partners is more prevalent among smokers [112] .
The prevalence of HPV infection seems to decrease in patients who quit smoking, but the time period after which nonsmoker levels are reached is not yet clear.
The association of smoking with HPV infection and development of anogenital warts, respectively, is well supported by current data. However, the cascade from HPV infection to the development of anogenital warts is still not well understood. Furthermore, prospective data on the impact of smoking on the spontaneous recovery rate of anogenital warts are still lacking.
Studies are more often performed for female than male patients, probably due to regular gynecologic controls. On the other hand, comparison of the studies did not reveal gender differences in the impact of smoking.
Conclusion
Most current data demonstrate an association between smoking, increased anogenital HPV infection, and development of anogenital warts. These data add to the long list of reasons for making smoking cessation a keystone of patient health. 
